Target intelligence / Profile preview

Succinate dehydrogenase complex (SDH or Complex II)

Target
SDH or Complex II
Molecular classification
Enzyme (oxidoreductase), Mitochondrial respiratory chain protein complex, Iron-sulfur protein family
01

Overview

Succinate dehydrogenase complex—also known as electron transport chain Complex II—is a multi-subunit enzyme embedded within the inner mitochondrial membrane. It uniquely participates both as an enzyme catalyzing oxidation of succinate to fumarate within the citric acid cycle and as an integral component transferring electrons from FADH₂ produced by this reaction directly into the electron transport chain via reduction of ubiquinone. The human enzyme consists of four subunits (SDHA, SDHB, SDHC, SDHD), with two hydrophilic catalytic subunits facing the matrix and two hydrophobic membrane anchor subunits. Unlike other complexes I/III/IV that pump protons across the membrane contributing directly to proton gradient formation for ATP synthesis, Complex II does not translocate protons but still contributes indirectly by feeding electrons into downstream complexes that do pump protons. Mutations affecting any subunit can result in inherited cancer predisposition syndromes or severe neurometabolic disease due to impaired oxidative phosphorylation capacity.

Other names
Electron transport chain complex IISuccinate ubiquinone oxidoreductaseRespiratory complex IISDH (succinate dehydrogenase)Mitochondrial complex II
02

Mechanism of action

For inhibitors: - Competitive inhibition at the succinate binding site or quinone binding site blocks electron transfer from succinate to ubiquinone. For potential therapeutics: - Modulation may alter mitochondrial respiration, ATP production, or reactive oxygen species generation.

03

Biological functions

Oxidation of succinate to fumarate in the citric acid (Krebs) cycleTransfer of electrons from succinate to ubiquinone in the electron transport chainCoupling tricarboxylic acid cycle and oxidative phosphorylation for ATP productionRegulation of mitochondrial respiratory function and cellular growthInvolvement in Ca²⁺ signaling and reactive oxygen species formation
04

Disease associations

Cancer (mutations linked to paraganglioma, pheochromocytoma, other tumors)Mitochondrial disease/complex II deficiency syndromes (neuromuscular, metabolic disorders)Neurodegenerative diseases (due to impaired energy metabolism or increased ROS)
05

Safety considerations

Inhibition can cause severe impairment of cellular energy metabolism leading to cell death.Chronic dysfunction is associated with increased ROS production, risk of tumorigenesis, neurodegeneration, lactic acidosis, myopathy.Targeting this enzyme requires caution due to its essential role in normal cell physiology.
06

Interacting drugs

Thenoyltrifluoroacetone (TTFA)

5 more in the full profile.

07

Biomarkers

Mutations or loss-of-function variants in any subunit gene (SDHA, SDHB, SDHC, SDHD) serve as biomarkers for hereditary paraganglioma/pheochromocytoma syndromes and some mitochondrial disorders.Accumulation of succinate can also be a biomarker.

Beyond the preview

Go deeper on Succinate dehydrogenase complex (SDH or Complex II).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Succinate dehydrogenase complex (SDH or Complex II).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call